ARWR - CIK 0000879407
The table below shows ARROWHEAD PHARMACEUTICALS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | $69.40M |
| Short-term investments | $1.60B | $714.97M | - | - | - | - |
| Receivables | $15.69M | $218.87M | $9.70M | $2.37M | $2.50M | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.84B |
| $1.17B |
| $946.92M |
| $1.14B |
| $570.54M |
| $450.06M |
| Property, plant & equipment | $374.82M | $378.58M | $381.05M | $384.80M | $387.07M | $375.91M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $2.27B | $1.60B | $1.38B | $1.57B | $1.01B | $883.76M |
| Accounts payable | $30.75M | $32.94M | $33.05M | $9.98M | $14.46M | $26.55M |
| Total current liabilities | $295.22M | $347.43M | $194.53M | $220.54M | $93.76M | $96.71M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$1.73B | -$1.60B | -$1.60B | -$1.43B | -$1.80B | -$1.45B |
| Total equity | $613.98M | $568.42M | $522.31M | $683.32M | $52.59M | $330.55M |